Zevra Therapeutics (ZVRA) Shares Outstanding (2014 - 2026)

Zevra Therapeutics' Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $19.1 million for Q1 2021.

• Quarterly Shares Outstanding (Entity) rose 439.71% year-over-year to $19.1 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $19.1 million (up 439.71% YoY) and the FY2020 annual result came in at $4.5 million, up 144.81% from the prior year.
• Shares Outstanding (Entity) was $19.1 million for Q1 2021 at Zevra Therapeutics, up from $4.5 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $19.1 million in Q1 2021 and bottomed at $915436.0 in Q1 2017.
• A 5-year average of $3.0 million and a median of $1.7 million in 2019 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2017 — Shares Outstanding (Entity) advanced 0.07% — and 2021, when it surged 439.71%.
• Zevra Therapeutics' Shares Outstanding (Entity) stood at $916089.0 in 2017, then increased by 22.33% to $1.1 million in 2018, then soared by 65.39% to $1.9 million in 2019, then soared by 144.81% to $4.5 million in 2020, then surged by 321.97% to $19.1 million in 2021.
• Business Quant data shows ZVRA's Shares Outstanding (Entity) at $19.1 million in Q1 2021, $4.5 million in Q4 2020, and $4.5 million in Q3 2020.